US00808Y4061 - Common Stock
AETHLON MEDICAL INC
NASDAQ:AEMD (12/19/2024, 8:16:12 PM)
Premarket: 0.401 -0.03 (-7.48%)0.4334
-0.23 (-34.39%)
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. The company is headquartered in San Diego, California and currently employs 14 full-time employees. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
AETHLON MEDICAL INC
11555 Sorrento Valley Road, Suite 203
San Diego CALIFORNIA 92123
P: 16199410360
CEO: Charles J. Fisher Jr
Employees: 14
Website: https://www.aethlonmedical.com/
What's going on in today's session
The trading volume of these stocks is deviating from the norm in today's session.
Top movers analysis in the middle of the day on 2024-12-19: top gainers and losers in today's session.
The session on Thursday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Wondering what's happening in Thursday's pre-market session? Find an overview in this article.
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Here you can normally see the latest stock twits on AEMD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: